Advertisement
Screener

Citadel Advisors LLC Historic Quarter Change: Foreign ADRs, Added, 2024 Q3

CITADEL ADVISORS LLC historic quarter change: Foreign ADRs, Added

In depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 793 positions, added to 554, reduced 514 and sold out of 741.

  • Q3 2024: Stock VERONA PHARMA PLC; Country of operation —; Class SPONSORED ADS; Shares before 102,615.
  • Q3 2024: Stock TOTALENERGIES SE; Country of operation —; Class SPONSORED ADS; Shares before 1,671.
  • Q3 2024: Stock EMPRESA DIST Y COMERCIAL NOR; Country of operation —; Class SPON ADR; Shares before 22,172.
  • Q3 2024: Stock EMEREN GROUP LTD; Country of operation —; Class SPONSORED ADS; Shares before 97,500.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q3 2024VERONA PHARMA PLC
CUSIP 925050106
—SPONSORED ADS102,6151,178,022+1,075,407$1,483,812$33,891,693+$32,407,8812024-11-14
Q3 2024TOTALENERGIES SE
CUSIP 89151E109
—SPONSORED ADS1,67190,678+89,007$111,422$5,859,612+$5,748,1902024-11-14
Q3 2024EMPRESA DIST Y COMERCIAL NOR
CUSIP 29244A102
—SPON ADR22,17250,976+28,804$363,399$1,129,628+$766,2292024-11-14
Q3 2024EMEREN GROUP LTD
CUSIP 75971T301
—SPONSORED ADS97,500127,840+30,340$146,250$345,168+$198,9182024-11-14
Q3 2024BANCO BBVA ARGENTINA S A
CUSIP 058934100
ArgentinaSPONSORED ADS2,05514,867+12,812$19,009$154,171+$135,1622024-11-14
Q3 2024EDAP TMS S A
CUSIP 268311107
FranceSPONSORED ADR35,03636,563+1,527$190,596$93,236-$97,3602024-11-14
Q3 2024I MAB
CUSIP 44975P103
Cayman IslandsSPONSORED ADS38,70898,389+59,681$64,642$122,002+$57,3602024-11-14
Q3 2024FANHUA INC
CUSIP 30712A103
—SPONSORED ADR12,38052,110+39,730$24,636$73,996+$49,3602024-11-14
Q3 2024BIT MINING LIMITED
CUSIP 055474209
—SPON ADR2,99115,532+12,541$7,896$36,500+$28,6042024-11-14
Q3 2024KAZIA THERAPEUTICS LTD
CUSIP 48669G105
—SPONSORED ADR4,56660,476+55,910$1,041$25,999+$24,9582024-11-14
Q3 2024CANGO INC
CUSIP 137586103
—ADS27,60139,725+12,124$46,094$70,711+$24,6172024-11-14
Q3 2024TRINITY BIOTECH PLC
CUSIP 896438504
—SPONS ADR NEW14,14814,151+3$29,286$15,566-$13,7202024-11-14
Q3 2024BARINTHUS BIOTHERAPEUTICS PL
CUSIP 91864C107
—ADS16,03727,717+11,680$22,452$34,092+$11,6402024-11-14
Q3 2024111 INC
CUSIP 68247Q102
—ADS34,74141,927+7,186$37,173$31,697-$5,4762024-11-14